Payment overview · 2025
General Payments
$128.85
6 reported records · 4 companies
Healthcare provider profile · identity verified
William H Light, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · GERMANTOWN, TN · NPI 1881646099
Verified facts
What the public records show
CMS Open Payments records show William H Light, M.D. received $128.85 in general payments during 2025 across 6 reported records.
Abbott Laboratories accounted for 46.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Kerendia.
Bayer Healthcare Pharmaceuticals Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Kerendia as an associated drug or biological on 138674 records involving 48458 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Kerendia by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $60.00 | 46.6% | 3 | 2025 |
| SANOFI PASTEUR INC. | Unresolved — no canonical attribution shown | $35.96 | 27.9% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $18.85 | 14.6% | 1 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $14.04 | 10.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $128.85 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BEYFORTUS Normalized: beyfortus |
Biological | SANOFI PASTEUR INC. | $35.96 | 1 | 2025 |
Source payment records
|
|||||
| FLUZONE HIGH-DOSE Normalized: fluzone high dose |
Biological | SANOFI PASTEUR INC. | $35.96 | 1 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $24.85 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $18.85 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $18.85 | 1 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $14.04 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Kerendia kerendia |
2025 | Kerendia | 2024 | 11 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. Exact reporting entity; no affiliate inference |
2025 | Kerendia open payments reported associated product |
CMS Open Payments — General Payments 138674 supporting records · 48458 recipient NPIs · example record 1225434663 |
Kerendia · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 740 | 224 |
| Amlodipine Besylate | Amlodipine Besylate | 687 | 197 |
| Levothyroxine Sodium | Levothyroxine Sodium | 393 | 108 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 381 | 131 |
| Omeprazole | Omeprazole | 378 | 108 |
| Losartan Potassium | Losartan Potassium | 349 | 102 |
| Pravastatin Sodium | Pravastatin Sodium | 273 | 87 |
| Metoprolol Succinate | Metoprolol Succinate | 264 | 71 |
| Pantoprazole Sodium | Pantoprazole Sodium | 246 | 80 |
| Lisinopril | Lisinopril | 245 | 75 |
| Alprazolam | Alprazolam | 227 | 54 |
| Tamsulosin Hcl | Tamsulosin Hcl | 208 | 69 |
| Metformin Hcl Er | Metformin Hcl | 179 | 52 |
| Allopurinol | Allopurinol | 178 | 50 |
| Fluticasone Propionate | Fluticasone Propionate | 175 | 71 |
| Meloxicam | Meloxicam | 170 | 60 |
| Carvedilol | Carvedilol | 167 | 49 |
| Gabapentin | Gabapentin | 167 | 68 |
| Simvastatin | Simvastatin | 160 | 51 |
| Furosemide | Furosemide | 155 | 55 |
| Potassium Chloride | Potassium Chloride | 155 | 47 |
| Metformin Hcl | Metformin Hcl | 151 | 43 |
| Lorazepam | Lorazepam | 140 | 30 |
| Irbesartan | Irbesartan | 138 | 42 |
| Montelukast Sodium | Montelukast Sodium | 133 | 41 |
| Eliquis | Apixaban | 126 | 29 |
| Famotidine | Famotidine | 125 | 41 |
| Hydrochlorothiazide | Hydrochlorothiazide | 121 | 37 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 118 | 28 |
| Alendronate Sodium | Alendronate Sodium | 117 | 32 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 113 | 34 |
| Spironolactone | Spironolactone | 110 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 102 | 26 |
| Clonazepam | Clonazepam | 98 | 22 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 98 | 30 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 96 | 32 |
| Ozempic | Semaglutide | 95 | 17 |
| Sertraline Hcl | Sertraline Hcl | 95 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 94 | 28 |
| Bupropion Xl | Bupropion Hcl | 92 | 25 |
| Zolpidem Tartrate | Zolpidem Tartrate | 92 | 25 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 85 | 26 |
| Ezetimibe | Ezetimibe | 84 | 31 |
| Finasteride | Finasteride | 83 | 24 |
| Tramadol Hcl | Tramadol Hcl | 82 | 16 |
| Trazodone Hcl | Trazodone Hcl | 80 | 22 |
| Metoprolol Tartrate | Metoprolol Tartrate | 78 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 77 | 20 |
| Glimepiride | Glimepiride | 75 | 23 |
| Paroxetine Hcl | Paroxetine Hcl | 74 | 23 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 72 | 13 |
| Jardiance | Empagliflozin | 70 | 16 |
| Chlorthalidone | Chlorthalidone | 66 | 19 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 65 | 30 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 65 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 59 | 49 |
| Trulicity | Dulaglutide | 57 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 56 | 20 |
| Diazepam | Diazepam | 55 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 55 | 19 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 53 | 18 |
| Citalopram Hbr | Citalopram Hydrobromide | 51 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 48 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 47 | 16 |
| Atenolol | Atenolol | 45 | 15 |
| Testosterone Cypionate | Testosterone Cypionate | 44 | 16 |
| Buspirone Hcl | Buspirone Hcl | 43 | 11 |
| Januvia | Sitagliptin Phosphate | 43 | 11 |
| Benazepril Hcl | Benazepril Hcl | 41 | 13 |
| Mounjaro | Tirzepatide | 41 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 41 | suppressed |
| Estradiol | Estradiol | 40 | 17 |
| Valsartan | Valsartan | 40 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 39 | 13 |
| Ondansetron Odt | Ondansetron | 39 | 14 |
| Telmisartan | Telmisartan | 39 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 38 | suppressed |
| Baclofen | Baclofen | 37 | 16 |
| Doxycycline Hyclate | Doxycycline Hyclate | 37 | 29 |
| Lovastatin | Lovastatin | 37 | 13 |
| Donepezil Hcl | Donepezil Hcl | 36 | 13 |
| Methylprednisolone | Methylprednisolone | 36 | 28 |
| Nebivolol Hcl | Nebivolol Hcl | 36 | suppressed |
| Ketoconazole | Ketoconazole | 35 | 13 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 33 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 33 | suppressed |
| Prednisone | Prednisone | 33 | 12 |
| Doxazosin Mesylate | Doxazosin Mesylate | 32 | suppressed |
| Celecoxib | Celecoxib | 31 | 12 |
| Clonidine Hcl | Clonidine Hcl | 31 | 11 |
| Doxepin Hcl | Doxepin Hcl | 31 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 31 | 12 |
| Terazosin Hcl | Terazosin Hcl | 31 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 30 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 30 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 30 | 29 |
| Synthroid | Levothyroxine Sodium | 29 | suppressed |
| Bumetanide | Bumetanide | 27 | suppressed |
| Mirtazapine | Mirtazapine | 27 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 27 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 27 | 18 |
| Lansoprazole | Lansoprazole | 26 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 26 | suppressed |
| Sotalol | Sotalol Hcl | 26 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 26 | suppressed |
| Pregabalin | Pregabalin | 25 | suppressed |
| Sucralfate | Sucralfate | 25 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 25 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 24 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 24 | suppressed |
| Temazepam | Temazepam | 24 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 23 | 12 |
| Mupirocin | Mupirocin | 23 | 12 |
| Azelastine Hcl | Azelastine Hcl | 22 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 22 | suppressed |
| Colchicine | Colchicine | 22 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 21 | suppressed |
| Xarelto | Rivaroxaban | 21 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 20 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 20 | suppressed |
| Torsemide | Torsemide | 20 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 19 | suppressed |
| Topiramate | Topiramate | 19 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 18 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 18 | suppressed |
| Levetiracetam | Levetiracetam | 18 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 18 | suppressed |
| Ramipril | Ramipril | 18 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Azithromycin | Azithromycin | 17 | suppressed |
| Cephalexin | Cephalexin | 17 | 11 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 17 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 17 | suppressed |
| Dutasteride | Dutasteride | 17 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 17 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 17 | suppressed |
| Fluconazole | Fluconazole | 17 | 12 |
| Leflunomide | Leflunomide | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 17 | 16 |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 16 | suppressed |
| Klor-Con M20 | Potassium Chloride | 16 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 16 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Sirolimus | Sirolimus | 16 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 16 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 16 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 15 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 15 | suppressed |
| Indapamide | Indapamide | 15 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 15 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 15 | suppressed |
| Ursodiol | Ursodiol | 15 | suppressed |
| Armour Thyroid | Thyroid,pork | 14 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 14 | 14 |
| Lumigan | Bimatoprost | 14 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Primidone | Primidone | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Cartia Xt | Diltiazem Hcl | 13 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 13 | suppressed |
| Entresto | Sacubitril/Valsartan | 13 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Gemtesa | Vibegron | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Premarin | Estrogens, Conjugated | 13 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 13 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | suppressed |
| Ibuprofen | Ibuprofen | 11 | suppressed |
| Kerendia | Finerenone | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Ranolazine Er | Ranolazine | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $128.85 · 6 records | Abbott Laboratories | BEYFORTUS, FLUZONE HIGH-DOSE, FREESTYLE LIBRE 3, Kerendia, OTEZLA, REPATHA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Kerendia play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Bayer Healthcare Pharmaceuticals Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error